Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silybum marianum for treatment of migraine
IRCT2016022026667N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jul 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silybum marianum extract in migraine, sponsored by Arak University of Medical Sciences. Started Jul 2017; status: completed.
02
Drugs
silybum marianum extract
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT2016022026667N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016022026667N1.